SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-240499
Filing Date
2021-08-09
Accepted
2021-08-09 16:26:17
Documents
16
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d771054d8k.htm   iXBRL 8-K 26215
2 EX-99.1 d771054dex991.htm EX-99.1 90446
3 EX-99.2 d771054dex992.htm EX-99.2 8395
7 GRAPHIC g771054g0807061903686.jpg GRAPHIC 3409
8 GRAPHIC g771054g85c92.jpg GRAPHIC 5832
  Complete submission text file 0001193125-21-240499.txt   275491

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nexi-20210809.xsd EX-101.SCH 2865
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20210809_lab.xml EX-101.LAB 18123
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20210809_pre.xml EX-101.PRE 11387
9 EXTRACTED XBRL INSTANCE DOCUMENT d771054d8k_htm.xml XML 3346
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 211156858
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences